These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13679663)

  • 1. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach.
    Prisco D; Marcucci R
    Pathophysiol Haemost Thromb; 2002; 32(5-6):308-11. PubMed ID: 13679663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion.
    Prisco D; Marcucci R; Bertini L; Gori AM
    Eur J Intern Med; 2002 May; 13(3):163-169. PubMed ID: 12020623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal vein occlusions: a review for the internist.
    Marcucci R; Sofi F; Grifoni E; Sodi A; Prisco D
    Intern Emerg Med; 2011 Aug; 6(4):307-14. PubMed ID: 21547483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
    Sartori MT; Barbar S; Donà A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
    Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal vein occlusions: diseases for the internist?].
    Prisco D; Bertini L; Marcucci R; Poli D
    Ann Ital Med Int; 2000; 15(1):75-84. PubMed ID: 10842895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
    Zhang H; Xia Y
    Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
    Pinna A; Carru C; Solinas G; Zinellu A; Carta F
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for retinal vein occlusion at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.
    Fiebai B; Ejimadu CS; Komolafe RD
    Niger J Clin Pract; 2014; 17(4):462-6. PubMed ID: 24909470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study.
    Ponto KA; Elbaz H; Peto T; Laubert-Reh D; Binder H; Wild PS; Lackner K; Pfeiffer N; Mirshahi A
    J Thromb Haemost; 2015 Jul; 13(7):1254-63. PubMed ID: 25894549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of coagulopathies and fibrinolytic abnormalities in central retinal vein occlusion in patients under 60 years of age].
    Tea S; Barrali M; Racadot E; Delbosc B
    J Fr Ophtalmol; 2013 Jan; 36(1):5-11. PubMed ID: 23238070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cilioretinal artery occlusion and central retinal vein occlusion complicating hyperhomocysteinemia: a case report].
    Berkani Z; Kitouni Y; Belhadj A; Sifi K; Abbadi N; Bellatrache C; Hartani D; Kherroubi R
    J Fr Ophtalmol; 2013 Sep; 36(7):e119-27. PubMed ID: 23731792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic abnormalities associated with various types of retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Podhajsky P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):180-96. PubMed ID: 11935275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal vein occlusion: evaluation of "classic" and "emerging" risk factors and treatment.
    Turello M; Pasca S; Daminato R; Dello Russo P; Giacomello R; Venturelli U; Barillari G
    J Thromb Thrombolysis; 2010 May; 29(4):459-64. PubMed ID: 19669864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors and visual prognosis of 407 patients with retinal vein occlusion].
    Zhang HR; Xia YJ
    Zhonghua Yan Ke Za Zhi; 1991 Sep; 27(5):271-4. PubMed ID: 1815918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral central retinal vein occlusion caused by malignant hypertension in a young patient.
    Balogh Z; Berta A; Pfliegler G; Nagy V
    Clin Exp Hypertens; 2011; 33(1):53-5. PubMed ID: 21166599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET).
    Paciullo F; Valeriani E; Porfidia A; Di Nisio M; Donadini MP; Marcucci R; Prisco D; Cagini C; Gresele P; Ageno W
    Blood Transfus; 2022 Jul; 20(4):341-347. PubMed ID: 35175186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.
    Janssen MC; den Heijer M; Cruysberg JR; Wollersheim H; Bredie SJ
    Thromb Haemost; 2005 Jun; 93(6):1021-6. PubMed ID: 15968383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of systemic diseases with retinal vein occlusive disease.
    Shrestha RK; Shrestha JK; Koirala S; Shah DN
    JNMA J Nepal Med Assoc; 2006; 45(162):244-8. PubMed ID: 17189969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.
    Squizzato A; Manfredi E; Bozzato S; Dentali F; Ageno W
    Thromb Haemost; 2010 Feb; 103(2):271-6. PubMed ID: 20126837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.